Register
Login:
Share:
Email Facebook Twitter


Leading commentator Josh Mahony from IG - are we seeing a US$ revaluation?


Ixico Share Chat (IXI)



Share Price: 33.50Bid: 33.00Ask: 34.00Change: 0.00 (0.00%)No Movement on Ixico
Spread: 1.00Spread as %: 3.03%Open: 33.50High: 33.50Low: 33.50Yesterday’s Close: 33.50


Share Discussion for Ixico


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

1
Next Ixico Share Chat Page

Thelagerkhan
Posts: 510
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:31.50
Results
22 May '17
Great results, great interview with CEO on Proactive.
A lot to look forward to.
 
Dierich
Posts: 5,218
Off Topic
Opinion:No Opinion
Price:30.50
IXI PIXI DIXI
13 Apr '17
79% of the shares spread between 4 holders

http://www.ixico.com/investors/shareholder-information

Research over for one day.
Dierich
Posts: 5,218
Off Topic
Opinion:No Opinion
Price:43.50
Nice ticker
2 Dec '16
Liked the sound of it so added it to my other dogs.

Research over.
cascudi
Posts: 212
Off Topic
Opinion:No Opinion
Price:28.00
boom
22 Nov '16
Nice raise
cascudi
Posts: 212
Off Topic
Opinion:No Opinion
Price:27.00
volume 3 times higher
22 Nov '16
3 times higher 3 months average. Contract win. Good balance sheet. Interesting company
Thelagerkhan
Posts: 510
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:28.00
RE: What a con
20 Oct '16
Hi Goldust, i do not think that there are too many shares freely available, which will work well if we have good news and as you say the reverse if we have bad news, I think that someone had been selling for the past few months and this brought the price down.
I feel that the price should be a bit higher yet and I am hoping that we get news of improved trading due to revenue from the trials announced lasy year building.
I was expecting a trading statement this week as it was announced on 19th Oct last year but may have been delayed as Dereck Hill is addressing the conference in Washington and he would probably prefer to be here.
goldust88
Posts: 1,092
Off Topic
Opinion:No Opinion
Price:28.00
What a con
20 Oct '16
Market makers pushing price up on tiny trades-will go up quick and often down again fast, very difficult to trade..
Thelagerkhan
Posts: 510
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:23.50
CAMD
19 Oct '16
I like it Dereck Hill is presenting at The Coalition Against Major Diseases in Washington, he commented.
Biosensor technologies are set to revolutionise drug development and patient care when used in the appropriate clinical context and regulatory framework. Ixico is delighted to share our cutting-edge work with regulators and experts in the pharmaceutical industry.
Thelagerkhan
Posts: 510
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:25.25
Contract
10 Oct '16
Another nice contract announced today.
There was a trading statement on 19th Oct last year so lets hope for more news next week.
Prior to this they had nine early stage contracts so revenue should be building.
Thoth2
Posts: 1,560
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:25.50
odd
15 Sep '16
I cleared out my holding here just because of another opportunity (luckily before the drop).
I would have thought it should be red hot for a takeover by the likes of IBM for its medical imaging analytics etc.
very surprised at the SP. will be back in
1
Next Ixico Share Chat Page




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.